Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa - Concepedia

Concepedia

Publication | Open Access

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa

DOI Full Paper Access

65

Citations

15

References

2021

Year

Houreratou Barry, Gaudensia Mutua, Hannah Kibuuka, Zacchaeus Anywaine, Sodiomon B. Sirima, Nicolas Méda, Omu Anzala, Serge Paul Eholié, Christine Bétard, Laura Richert,

Abstract

ClinicalTrials.gov NCT02564523.

References

	Year	Citations

Page 1